Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Clinical trial NCT02224729 · COMPLETED

Trial details

NCT number

NCT02224729

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-08-25

Primary completion

2016-04-21

Enrollment

24

View on ClinicalTrials.gov